• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病中的血小板、凝血与纤维蛋白溶解:它们在血管闭塞中可能发挥的作用。

Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion.

作者信息

Francis R B

机构信息

Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.

出版信息

Blood Coagul Fibrinolysis. 1991 Apr;2(2):341-53. doi: 10.1097/00001721-199104000-00018.

DOI:10.1097/00001721-199104000-00018
PMID:1893065
Abstract

Recent evidence suggests that sickle cell disease (SCD) can be considered a hypercoagulable state, in which both platelet activation and thrombin generation are abnormally increased. Although thrombosis is now known to play an important role in at least one of the vasocclusive complications of SCD, namely stroke, the significance of hypercoagulability in the pathogenesis of vascular occlusion in SCD remains unclear. This review summarizes current evidence regarding platelet, coagulation, and fibrinolytic abnormalities in SCD and their possible role in vascular occlusion. Potential implications for therapy are also discussed.

摘要

最近的证据表明,镰状细胞病(SCD)可被视为一种高凝状态,其中血小板活化和凝血酶生成均异常增加。尽管现在已知血栓形成在SCD的至少一种血管闭塞性并发症(即中风)中起重要作用,但高凝状态在SCD血管闭塞发病机制中的意义仍不清楚。本综述总结了目前关于SCD中血小板、凝血和纤溶异常及其在血管闭塞中可能作用的证据。还讨论了对治疗的潜在影响。

相似文献

1
Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion.镰状细胞病中的血小板、凝血与纤维蛋白溶解:它们在血管闭塞中可能发挥的作用。
Blood Coagul Fibrinolysis. 1991 Apr;2(2):341-53. doi: 10.1097/00001721-199104000-00018.
2
Thrombosis and sickle cell disease.血栓与镰状细胞病。
Semin Thromb Hemost. 2011 Apr;37(3):226-36. doi: 10.1055/s-0031-1273087. Epub 2011 Mar 31.
3
Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.在镰状细胞病中凝血酶生成和细胞依赖性高凝状态。
J Thromb Haemost. 2016 Oct;14(10):1941-1952. doi: 10.1111/jth.13416. Epub 2016 Aug 31.
4
Large-vessel occlusion in sickle cell disease: pathogenesis, clinical consequences, and therapeutic implications.镰状细胞病中的大血管闭塞:发病机制、临床后果及治疗意义
Med Hypotheses. 1991 Jun;35(2):88-95. doi: 10.1016/0306-9877(91)90029-x.
5
Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.循环血小板和红细胞微粒在患有镰状细胞病的婴幼儿中的变化:与心血管并发症的关系。
Platelets. 2013;24(8):605-14. doi: 10.3109/09537104.2012.749397. Epub 2012 Dec 18.
6
Hypercoagulability in sickle cell disease: new approaches to an old problem.镰状细胞病中的高凝状态:针对老问题的新方法。
Hematology Am Soc Hematol Educ Program. 2007:91-6. doi: 10.1182/asheducation-2007.1.91.
7
Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.镰状细胞病的凝血异常:与临床结局的关系及疾病修饰疗法的影响。
Blood Rev. 2016 Jul;30(4):245-56. doi: 10.1016/j.blre.2015.12.003. Epub 2015 Dec 24.
8
Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology.镰状细胞病中的止血改变:与疾病病理生理学的关系。
Pediatr Pathol Mol Med. 2001 Jan-Feb;20(1):27-46.
9
Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism.镰状细胞病中的高凝状态:血栓炎症机制。
Hemoglobin. 2023 Nov;47(6):205-214. doi: 10.1080/03630269.2023.2301026. Epub 2024 Jan 22.
10
Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion.活化血小板中的血小板反应蛋白在生理血流状态下促进镰状红细胞与人类微血管内皮细胞的黏附:血小板活化在镰状细胞血管阻塞中的潜在作用。
Blood. 1993 Apr 15;81(8):2137-43.

引用本文的文献

1
Circulating extracellular vesicles as novel biomarkers for pulmonary arterial hypertension in patients with systemic lupus erythematosus.循环细胞外囊泡作为系统性红斑狼疮肺动脉高压患者的新型生物标志物。
Front Immunol. 2024 Sep 19;15:1374100. doi: 10.3389/fimmu.2024.1374100. eCollection 2024.
2
Cardiovascular consequences of sickle cell disease.镰状细胞病的心血管后果。
Biophys Rev (Melville). 2022 Aug 8;3(3):031302. doi: 10.1063/5.0094650. eCollection 2022 Sep.
3
The Role of RBC Oxidative Stress in Sickle Cell Disease: From the Molecular Basis to Pathologic Implications.
红细胞氧化应激在镰状细胞病中的作用:从分子基础到病理意义
Antioxidants (Basel). 2021 Oct 13;10(10):1608. doi: 10.3390/antiox10101608.
4
Cardiac pathophysiology in sickle cell disease.镰状细胞病的心脏病理生理学
J Thromb Thrombolysis. 2021 Jul;52(1):248-259. doi: 10.1007/s11239-021-02414-6. Epub 2021 Mar 7.
5
The molecular basis for the prothrombotic state in sickle cell disease.镰状细胞病中促血栓形成状态的分子基础。
Haematologica. 2020 Oct 1;105(10):2368-2379. doi: 10.3324/haematol.2019.239350.
6
Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology.镰状细胞病:静脉血栓形成病理生理学的范例。
Int J Mol Sci. 2020 Jul 25;21(15):5279. doi: 10.3390/ijms21155279.
7
Severity of Anaemia Has Corresponding Effects on Coagulation Parameters of Sickle Cell Disease Patients.贫血严重程度对镰状细胞病患者的凝血参数有相应影响。
Diseases. 2019 Dec 17;7(4):59. doi: 10.3390/diseases7040059.
8
MEK1/2 as a Therapeutic Target in Sickle Cell Disease.MEK1/2作为镰状细胞病的治疗靶点
Int J Blood Res Disord. 2019;6. doi: 10.23937/2469-5696/1410038. Epub 2019 Apr 4.
9
Hematological parameters in Ghanaian sickle cell disease patients.加纳镰状细胞病患者的血液学参数
J Blood Med. 2018 Oct 31;9:203-209. doi: 10.2147/JBM.S169872. eCollection 2018.
10
Successful pulmonary thromboendarterectomy in a patient with sickle cell disease and associated resolution of a leg ulcer.镰状细胞病患者成功进行肺动脉血栓内膜剥脱术及腿部溃疡随之愈合
Lung India. 2018 Jan-Feb;35(1):73-77. doi: 10.4103/lungindia.lungindia_47_17.